Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (1595)
All Articles published online
|
Oct 7, 2007 (publication date) through Apr 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Chen LB, Tong JL, Song HZ, Zhu H, Wang YC. 18F-DG PET/CT in detection of recurrence and metastasis of colorectal cancer. World J Gastroenterol 2007; 13(37): 5025-5029 [PMID: 17854148 DOI: 10.3748/wjg.v13.i37.5025] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v13/i37/5025.htm |
| Number | Citing Articles |
| 1 |
Ginseppe Garcea, Seok Ling Ong, Guy J. Maddern. The current role of PET-CT in the characterization of hepatobiliary malignancies. HPB 2009; 11(1): 4 doi: 10.1111/j.1477-2574.2008.00009.x
|
| 2 |
Antonio Crucitti, Ugo Grossi, Lucia Leccisotti, Fabio Maggi, Riccardo Ricci, Andrea Mazzari, Pasquina M. C. Tomaiuolo, Alessandro Giordano. Food residue granuloma mimicking metastatic disease on FDG-PET/CT. Japanese Journal of Radiology 2013; 31(5): 349 doi: 10.1007/s11604-013-0184-x
|
| 3 |
Jai Hyuen Lee, Seok Gun Park, Keum Nahn Jee, Dong Guk Park, Hwan Namgung, Il Han Song. Performance of FDG PET/CT in postoperative colorectal cancer patients with a suspected recurrence and a normal CEA level. Nuclear Medicine Communications 2010; 31(6): 576 doi: 10.1097/MNM.0b013e32833845b7
|
| 4 |
Anthony Visioni, Julian Kim. Positron Emission Tomography for Benign and Malignant Disease. Surgical Clinics of North America 2011; 91(1): 249 doi: 10.1016/j.suc.2010.10.012
|
| 5 |
Roberto Garcia Figueiras, Vicky Goh, Anwar R. Padhani, Anaberta Bermudez Naveira, Antonio Gomez Caamaño, Carmen Villalba Martin. The Role of Functional Imaging in Colorectal Cancer. American Journal of Roentgenology 2010; 195(1): 54 doi: 10.2214/AJR.10.4422
|
| 6 |
Sung Hoon Sim, Yu Jung Kim, Do-Youn Oh, Se-Hoon Lee, Dong-Wan Kim, Won Jun Kang, Seock-Ah Im, Tae-You Kim, Woo Ho Kim, Dae Seog Heo, Yung-Jue Bang. The role of PET/CT in detection of gastric cancer recurrence. BMC Cancer 2009; 9(1) doi: 10.1186/1471-2407-9-73
|
| 7 |
Shamim Ahmed Shamim, Rakesh Kumar, Dhanapathi Halanaik, Varun Shandal, Rama Mohan Reddy, Chandra Shekhar Bal, Arun Malhotra. Role of FDG-PET/CT in detection of recurrent disease in colorectal cancer. Nuclear Medicine Communications 2010; 31(6): 590 doi: 10.1097/MNM.0b013e328338a120
|
| 8 |
Yu-Yi Huang, Pei-Ing Lee, Mei-Ching Liu, Chien-Chih Chen, Kuo-Cheng Huang, Andrew T. Huang. A General Cutoff Level Combined With Personalized Dynamic Change of Serum Carcinoembryonic Antigen Can Suggest Timely Use of FDG PET for Early Detection of Recurrent Colorectal Cancer. Clinical Nuclear Medicine 2015; 40(10): e465 doi: 10.1097/RLU.0000000000000900
|
| 9 |
Anqin Han, Jie Xue, Dongyuan Zhu, Jinsong Zheng, Jinbo Yue, Jinming Yu. Clinical value of 18F-FDG PET/CT in postoperative monitoring for patients with colorectal carcinoma. Cancer Epidemiology 2011; 35(5): 497 doi: 10.1016/j.canep.2011.01.002
|
| 10 |
Savas Karyagar, Sevda Saglampinar Karyagar, Can Kece, Bulent Ozdil. Subcutaneous Metastases of Colorectal Cancer Detected With PET/CT. Clinical Nuclear Medicine 2010; 35(4): 267 doi: 10.1097/RLU.0b013e3181d19084
|
| 11 |
Zaiba Shafik Dawood, Laura Alaimo, Henrique A. Lima, Zorays Moazzam, Chanza Shaikh, Ahmed Sayed Ahmed, Muhammad Musaab Munir, Yutaka Endo, Timothy M. Pawlik. Circulating Tumor DNA, Imaging, and Carcinoembryonic Antigen: Comparison of Surveillance Strategies Among Patients Who Underwent Resection of Colorectal Cancer—A Systematic Review and Meta-analysis. Annals of Surgical Oncology 2023; 30(1): 259 doi: 10.1245/s10434-022-12641-7
|
| 12 |
Albert Dirisamer, Benjamin S. Halpern, Daniel Flöry, Florian Wolf, Mohsen Beheshti, Marius E. Mayerhoefer, Werner Langsteger. Performance of integrated FDG-PET/contrast-enhanced CT in the staging and restaging of colorectal cancer: Comparison with PET and enhanced CT. European Journal of Radiology 2010; 73(2): 324 doi: 10.1016/j.ejrad.2008.10.030
|
| 13 |
Kazuhiro Kitajima, Koji Murakami, Erena Yamasaki, Yasushi Domeki, Masahiro Tsubaki, Masakatsu Sunagawa, Yasushi Kaji, Narufumi Suganuma, Kazuro Sugimura. Performance of integrated FDG PET/contrast-enhanced CT in the diagnosis of recurrent colorectal cancer: Comparison with integrated FDG PET/non-contrast-enhanced CT and enhanced CT. European Journal of Nuclear Medicine and Molecular Imaging 2009; 36(9): 1388 doi: 10.1007/s00259-009-1081-5
|
| 14 |
Michael Gade, Magdalena Kubik, Rune V. Fisker, Ole Thorlacius-Ussing, Lars J. Petersen. Diagnostic value of 18F-FDG PET/CT as first choice in the detection of recurrent colorectal cancer due to rising CEA. Cancer Imaging 2015; 15(1) doi: 10.1186/s40644-015-0048-y
|
| 15 |
Monique Maas, Iris J. G. Rutten, Patty J. Nelemans, Doenja M. J. Lambregts, Vincent C. Cappendijk, Geerard L. Beets, Regina G. H. Beets-Tan. What is the most accurate whole-body imaging modality for assessment of local and distant recurrent disease in colorectal cancer? A meta-analysis. European Journal of Nuclear Medicine and Molecular Imaging 2011; 38(8): 1560 doi: 10.1007/s00259-011-1785-1
|
| 16 |
Mathieu Gauthé, Marion Richard-Molard, Wulfran Cacheux, Pierre Michel, Jean-Louis Jouve, Emmanuel Mitry, Jean-Louis Alberini, Astrid Lièvre. Role of fluorine 18 fluorodeoxyglucose positron emission tomography/computed tomography in gastrointestinal cancers. Digestive and Liver Disease 2015; 47(6): 443 doi: 10.1016/j.dld.2015.02.005
|
| 17 |
Roberto García-Figueiras, Sandra Baleato-González, Antonio Gómez-Caamaño, Ana Alvarez-Castro, Jesús Paredes-Cotoré. Functional Imaging in Oncology. 2014; : 923 doi: 10.1007/978-3-642-40582-2_15
|
| 18 |
Ramit Lamba, Ghaneh Fananazapir, Michael T. Corwin, Vijay P. Khatri. Diagnostic Imaging of Hepatic Lesions in Adults. Surgical Oncology Clinics of North America 2014; 23(4): 789 doi: 10.1016/j.soc.2014.07.003
|
| 19 |
S Mohammed Ali, Anthony Antoniou, John Beynon, Aneel Bhangu, Pradeep Bose, Kirsten Boyle, Graham Branagan, Gina Brown, David Burling, George J Chang, Susan K Clark, Patrick Colquhoun, Christopher H Crane, Ara Darzi, Prajnan Das, Johannes H W de Wilt, Conor P Delaney, Anant Desai, Mark Davies, David Dietz, Eric J Dozois, Michael Duff, Adam Dziki, J Edward Fitzgerald, Frank A Frizelle, Bruce George, Mark L George, Panagiotis Georgiou, Rob Glynne-Jones, Robert D Goldin, Arun Gupta, Deena Harji, Dean A Harris, Maria Hawkins, Alexander G Heriot, Torbjörn Holm, Roel Hompes, Lee Jeys, John T Jenkins, Ravi P Kiran, Cherry E Koh, Soren Laurberg, Wai L Law, A Sender Liberman, Michele Marshall, David R McArthur, Alex H Mirnezami, Brendan Moran, Neil Mortenson, Eddie Myers, R John Nicholls, P Ronan O'Connell, Sarah T O'Dwyer, Alex Oliver, Arvind Pallan, Prashant Patel, Uday B Patel, Simon Radley, Kelvin W D Ramsey, Peter C Rasmussen, Carole Richard, Harm J T Rutten, Peter Sagar, David Sebag-Montefiore, Michael J Solomon, Luca Stocchi, Carol J Swallow, Diana Tait, Emile Tan, Paris P Tekkis, Nicholas van As, Te Vuong, Theo Wiggers, Malcolm Wilson, Desmond Winter, Christopher Woodhouse. Consensus statement on the multidisciplinary management of patients with recurrent and primary rectal cancer beyond total mesorectal excision planes. British Journal of Surgery 2013; 100(8): E1 doi: 10.1002/bjs.9192_1
|
| 20 |
Yang Joon Kang, Sook Hee Heo, Jin Woong Kim, Sang Soo Shin, Nam Kyu Chang, Song Choi, Chol Kyoon Cho, Hee Seung Bom, Yong Yeon Jeong, Heoung Keun Kang. Detection of Intra-Abdominal Tumor Recurrence in Patients with Cholangiocarcinoma: Comparison of Contrast-Enhanced MDCT and18F FDG-PET/CT. Journal of the Korean Society of Radiology 2010; 62(2): 149 doi: 10.3348/jksr.2010.62.2.149
|
| 21 |
J. Gong, W. Cao, Z. Zhang, Y. Deng, L. Kang, P. Zhu, Z. Liu, Z. Zhou. Diagnostic efficacy of whole-body diffusion-weighted imaging in the detection of tumour recurrence and metastasis by comparison with 18F-2-fluoro-2-deoxy-D-glucose positron emission tomography or computed tomography in patients with gastrointestinal cancer. Gastroenterology Report 2015; 3(2): 128 doi: 10.1093/gastro/gou078
|
| 22 |
Reid B. Adams, Thomas A. Aloia, Evelyne Loyer, Timothy M. Pawlik, Bachir Taouli, Jean‐Nicolas Vauthey. Selection for hepatic resection of colorectal liver metastases: expert consensus statement. HPB 2013; 15(2): 91 doi: 10.1111/j.1477-2574.2012.00557.x
|
| 23 |
M J STEWARD, D MURRAY. Staging of colorectal cancer. Imaging 2013; 22(1): 20120024 doi: 10.1259/imaging.20120024
|
| 24 |
Secondo Lastoria, Luigi Aloj, Corradina Caracò, Raffaele Farese, Anna Morisco. Multimodal Treatment of Recurrent Pelvic Colorectal Cancer. Updates in Surgery 2016; : 39 doi: 10.1007/978-88-470-5767-8_4
|
| 25 |
Ur Metser, John You, Sean McSweeney, Marc Freeman, Aaron Hendler. Assessment of Tumor Recurrence in Patients With Colorectal Cancer and Elevated Carcinoembryonic Antigen Level: FDG PET/CT Versus Contrast-Enhanced 64-MDCT of the Chest and Abdomen. American Journal of Roentgenology 2010; 194(3): 766 doi: 10.2214/AJR.09.3205
|
| 26 |
Ya-Ming Li, David Yang, Xue-Na Li. Personalized Pathway-Activated Systems Imaging in Oncology. 2017; : 223 doi: 10.1007/978-981-10-3349-0_13
|
| 27 |
C. Jones, S.A. Badger, L.D. McKie, T. Diamond, M.A. Taylor, T.B. Lynch. PET-CT accurately predicts the pre-operative characteristics of colorectal hepatic metastases. European Journal of Surgical Oncology (EJSO) 2012; 38(12): 1184 doi: 10.1016/j.ejso.2012.07.001
|
| 28 |
Jonas Francisco Y. Santiago. Positron Emission Tomography with Computed Tomography (PET/CT). 2015; : 115 doi: 10.1007/978-3-319-05518-3_10
|
| 29 |
M.A. Ochoa-Figueroa, J. Uña-Gorospe, A. Allende-Riera, J.C. Cárdenas-Negro, J. Muñoz-Iglesias, D. Cabello-García, M. De Sequera-Rahola, E. Martínez-Gimeno. Utilidad de la PET-TC con baja dosis de 18F-FDG en pacientes con sospecha de recurrencia de carcinoma colorrectal en métodos diagnósticos convencionales. Revista Española de Medicina Nuclear e Imagen Molecular 2012; 31(5): 249 doi: 10.1016/j.remn.2011.09.006
|
| 30 |
Y. Nakamoto, K. Togashi, T. Kaneta, H. Fukuda, K. Nakajima, K. Kitajima, K. Murakami, H. Fujii, M. Satake, U. Tateishi, K. Kubota, M. Senda. Clinical Value of Whole-body FDG-PET for Recurrent Gastric Cancer: A Multicenter Study. Japanese Journal of Clinical Oncology 2009; 39(5): 297 doi: 10.1093/jjco/hyp010
|
| 31 |
Michael Blake, Michael Moore. Abdominal Imaging. 2011; : 146 doi: 10.1016/B978-1-4160-5449-8.00023-8
|
| 32 |
Germán Andrés Jiménez Londoño, Ana María García Vicente, Victoria Sánchez Pérez, Fátima Jiménez Aragón, Alberto León Martin, Juana María Cano Cano, Esther Domínguez Ferreras, Ober Van Gómez López, Javier Espinosa Arranz, Ángel María Soriano Castrejón. 18 F-FDG PET/contrast enhanced CT in the standard surveillance of high risk colorectal cancer patients. European Journal of Radiology 2014; 83(12): 2224 doi: 10.1016/j.ejrad.2014.08.016
|
| 33 |
Nikhil Kapse, Vicky Goh. Functional Imaging of Colorectal Cancer: Positron Emission Tomography, Magnetic Resonance Imaging, and Computed Tomography. Clinical Colorectal Cancer 2009; 8(2): 77 doi: 10.3816/CCC.2009.n.013
|
| 34 |
Hirofumi Shibata, Ukihide Tateishi, Tomio Inoue. Clinical PET and PET/CT. 2013; : 273 doi: 10.1007/978-1-4419-0802-5_24
|
| 35 |
Joo Young Lee, Soon Man Yoon, Jeong Tae Kim, Ki Bae Kim, Mi Jin Kim, Jae Geun Park, Taek-Gu Lee, Sang-Jeon Lee, Sung Soo Koong, Joung-Ho Han, Hee Bok Chae, Seon Mee Park, Sei Jin Youn. Diagnostic and prognostic value of preoperative 18F-fluorodeoxyglucose positron emission tomography/computed tomography for colorectal cancer: comparison with conventional computed tomography. Intestinal Research 2017; 15(2): 208 doi: 10.5217/ir.2017.15.2.208
|
| 36 |
G. P. Schmidt, A. Baur-Melnyk, A. Haug, S. Utzschneider, C. R. Becker, R. Tiling, M. F. Reiser, K. A. Hermann. Whole-body MRI at 1.5 T and 3 T compared with FDG-PET-CT for the detection of tumour recurrence in patients with colorectal cancer. European Radiology 2009; 19(6): 1366 doi: 10.1007/s00330-008-1289-y
|
| 37 |
S. Mirpour, P. Meteesatien, A.H. Khandani. Does hyperglycemia affect the diagnostic value of 18F-FDG PET/CT?. Revista Española de Medicina Nuclear e Imagen Molecular (English Edition) 2012; 31(2): 71 doi: 10.1016/j.remnie.2012.03.007
|
| 38 |
William Makis, David Kurzencwyg, Marc Hickeson. 18F-FDG PET/CT superior to serum CEA in detection of colorectal cancer and its recurrence. Clinical Imaging 2013; 37(6): 1094 doi: 10.1016/j.clinimag.2013.04.004
|
| 39 |
Remon Zaher Elia, Rafik Abdelazem Elbastawessy, Hanaa Abdelkader Abdelmgeguid, Ahmed Mohamed Bassiouny. FDG PET/CT in follow UP patients with colorectal carcinoma after adjuvant chemotherapy. Egyptian Journal of Radiology and Nuclear Medicine 2021; 52(1) doi: 10.1186/s43055-021-00655-2
|
| 40 |
Nan-Jing Peng, Chin Hu, Tai-Ming King, Yu-Li Chiu, Jui-Ho Wang, Ren-Shyan Liu. Detection of Resectable Recurrences in Colorectal Cancer Patients with 2-[18F]Fluoro-2-Deoxy-D-Glucose-Positron Emission Tomography/Computed Tomography. Cancer Biotherapy and Radiopharmaceuticals 2013; 28(6): 479 doi: 10.1089/cbr.2012.1382
|
| 41 |
S. Mirpour, P. Meteesatien, A.H. Khandani. Does hyperglycemia affect the diagnostic value of 18F-FDG PET/CT?. Revista Española de Medicina Nuclear e Imagen Molecular 2012; 31(2): 71 doi: 10.1016/j.remn.2011.05.006
|
| 42 |
Ahmed Mohamed Hussein, Mohamed Amin Nassef. Assessment of postoperative local and distant recurrence in colorectal cancer patients: Comparison between PET/CT and CECT. The Egyptian Journal of Radiology and Nuclear Medicine 2016; 47(2): 431 doi: 10.1016/j.ejrnm.2016.02.002
|
| 43 |
Wolfgang Luboldt, Teresa Volker, Bärbel Wiedemann, Klaus Zöphel, Ursula Wehrmann, Arne Koch, Todd Toussaint, Nasreddin Abolmaali, Markus Middendorp, Daniela Aust, Jörg Kotzerke, Frank Grünwald, Thomas J. Vogl, Hans-Joachim Luboldt. Detection of relevant colonic neoplasms with PET/CT: promising accuracy with minimal CT dose and a standardised PET cut-off. European Radiology 2010; 20(9): 2274 doi: 10.1007/s00330-010-1772-0
|
| 44 |
Yukihiko Karasawa. An FDG-PET/CT-Positive Lesion Mimicking Local Recurrence of Colon Cancer 5 Years after Radical Colectomy. American Journal of Case Reports 2015; 16: 149 doi: 10.12659/AJCR.891129
|
| 45 |
Robert J. Gillies, Ian Robey, Robert A. Gatenby. Causes and Consequences of Increased Glucose Metabolism of Cancers. Journal of Nuclear Medicine 2008; 49(Suppl 2): 24S doi: 10.2967/jnumed.107.047258
|
| 46 |
Debing Shi, Guoxiang Cai, Junjie Peng, Dawei Li, Xinxiang Li, Ye Xu, Sanjun Cai. The preoperative SUVmax for 18F-FDG uptake predicts survival in patients with colorectal cancer. BMC Cancer 2015; 15(1) doi: 10.1186/s12885-015-1991-5
|
| 47 |
Julian Kirchner, Benedikt M. Schaarschmidt, Firas Kour, Lino M. Sawicki, Ole Martin, Johannes Bode, Stephan vom Dahl, Verena Keitel, Dieter Häussinger, Christina Antke, Christian Buchbender, Gerald Antoch, Philipp Heusch. Incidental 18F-FDG uptake in the colon: value of contrast-enhanced CT correlation with colonoscopic findings. European Journal of Nuclear Medicine and Molecular Imaging 2020; 47(4): 778 doi: 10.1007/s00259-019-04579-y
|
| 48 |
Junichi Shindoh, Giuseppe Zimmitti, Jean-Nicolas Vauthey. Surgical Oncology. 2015; : 449 doi: 10.1007/978-1-4939-1423-4_19
|
| 49 |
Hamid Dahmarde, Fateme Parooie, Morteza Salarzaei. Is 18F-FDG PET/CT an Accurate Way to Detect Lymph Node Metastasis in Colorectal Cancer: A Systematic Review and Meta-Analysis. Contrast Media & Molecular Imaging 2020; 2020: 1 doi: 10.1155/2020/5439378
|
| 50 |
M.S. Teh, H.Y. Chong, A.C. Roslani. Impact of PET scan in staging and managing primary rectal cancer. Asian Journal of Surgery 2019; 42(3): 520 doi: 10.1016/j.asjsur.2018.10.006
|
| 51 |
Maria Mathew D'Souza, Rajnish Sharma, Anupam Mondal, Abhinav Jaimini, Madhavi Tripathi, Sanjiv Kumar Saw, Dinesh Singh, Anil Mishra, Rajendra Prasad Tripathi. Prospective evaluation of CECT and 18F-FDG-PET/CT in detection of hepatic metastases. Nuclear Medicine Communications 2009; 30(2): 117 doi: 10.1097/MNM.0b013e32831ec57b
|
| 52 |
M J STEWARD, D MURRAY. Staging of colorectal cancer. Imaging 2013; 22(1): 20110078 doi: 10.1259/imaging.20110078
|
| 53 |
|
| 54 |
N. F. Sørensen, A. B. Jensen, P. Wille‐Jørgensen, L. Friberg, L. Rørdam, L. Ingeman, V. Hennild. Strict follow‐up programme including CT and 18F‐FDG‐PET after curative surgery for colorectal cancer. Colorectal Disease 2010; 12(10Online) doi: 10.1111/j.1463-1318.2009.02150.x
|
| 55 |
Yun-Gyoo Lee, Sae-Won Han, Do-Youn Oh, Eui Kyu Chie, Jin-Young Jang, Seock-Ah Im, Tae-You Kim, Sun-Whe Kim, Sung Whan Ha, Yung-Jue Bang. Diagnostic performance of contrast enhanced CT and 18F-FDG PET/CT in suspicious recurrence of biliary tract cancer after curative resection. BMC Cancer 2011; 11(1) doi: 10.1186/1471-2407-11-188
|
| 56 |
Yu-Yu Lu, Jin-Hua Chen, Chun-Ru Chien, William Tzu-Liang Chen, Shih-Chuan Tsai, Wan-Yu Lin, Chia-Hung Kao. Use of FDG-PET or PET/CT to detect recurrent colorectal cancer in patients with elevated CEA: a systematic review and meta-analysis. International Journal of Colorectal Disease 2013; 28(8): 1039 doi: 10.1007/s00384-013-1659-z
|
| 57 |
Francisco Igor B Macedo, Tafadzwa Makarawo. Colorectal hepatic metastasis: Evolving therapies. World Journal of Hepatology 2014; 6(7): 453-463 doi: 10.4254/wjh.v6.i7.453
|
| 58 |
Alessandro Borello, Nadia Russolillo, Roberto Lo Tesoriere, Serena Langella, Martina Guerra, Alessandro Ferrero. Diagnostic performance of the FDG-PET/CT in patients with resected mucinous colorectal liver metastases. The Surgeon 2021; 19(5): e140 doi: 10.1016/j.surge.2020.09.004
|
| 59 |
Brian M. Zeglis, Jason P. Holland, Artem Y. Lebedev, Melchor V. Cantorias, Jason S. Lewis. Nuclear Oncology. 2013; : 35 doi: 10.1007/978-0-387-48894-3_3
|
| 60 |
C. Brendle, N. F. Schwenzer, H. Rempp, H. Schmidt, C. Pfannenberg, C. la Fougère, K. Nikolaou, C. Schraml. Assessment of metastatic colorectal cancer with hybrid imaging: comparison of reading performance using different combinations of anatomical and functional imaging techniques in PET/MRI and PET/CT in a short case series. European Journal of Nuclear Medicine and Molecular Imaging 2016; 43(1): 123 doi: 10.1007/s00259-015-3137-z
|
| 61 |
M.A. Ochoa-Figueroa, J. Uña-Gorospe, A. Allende-Riera, J.C. Cárdenas-Negro, J. Muñoz-Iglesias, D. Cabello-García, M. De Sequera-Rahola, E. Martínez-Gimeno. Utility of low dose 18F-FDG PET-CT in patients with suspected colorectal carcinoma recurrence using conventional diagnostic methods. Revista Española de Medicina Nuclear e Imagen Molecular (English Edition) 2012; 31(5): 249 doi: 10.1016/j.remnie.2012.07.003
|
| 62 |
Kinney Kinney, Kinney Kinney, Kinney Kinney. PET/CT in the evaluation of colorectal carcinoma. Applied Radiology 2008; : 33 doi: 10.37549/AR1664
|
| 63 |
C. Gielen, I. Sanli, L. Stroeken, A. Botterweck, K. Hulsewé, A. Hoofwijk. Staging chest radiography is not useful in patients with colorectal cancer. European Journal of Surgical Oncology (EJSO) 2009; 35(11): 1174 doi: 10.1016/j.ejso.2009.02.012
|
| 64 |
Nyree Griffin, Vicky Goh. Functional imaging of the bowel. Abdominal Imaging 2013; 38(6): 1203 doi: 10.1007/s00261-013-0030-8
|
| 65 |
Samar R. Ragheb, Sherine M. Sharara. Can PET/CT detect recurrence in post-operative colorectal carcinoma patients with elevated CEA level?. Egyptian Journal of Radiology and Nuclear Medicine 2020; 51(1) doi: 10.1186/s43055-020-00170-w
|
| 66 |
Kevin P. Banks, Won S. Song. Role of Positron Emission Tomography–Computed Tomography in Gastrointestinal Malignancies. Radiologic Clinics of North America 2013; 51(5): 799 doi: 10.1016/j.rcl.2013.05.003
|